This change translated into a sera with a significant capacity to stall breast cancer cell growth, migration, invasion, and transforming growth factor-beta (TGF-β)-dependent epithelial-mesenchymal transition [33]. This evidence concerns the gene TGFB1 and breast carcinoma.